Scientific Reports - Factors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection

Four in ten healthcare workers worldwide who were infected with SARS-CoV-2 during the pandemic developed long covid, and a quarter still had symptoms after a year, a report has found. The report by t...

A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.

A national prospective study of patients requiring hospitalization for COVID-19 demonstrates global cognitive deficits at 1 year, associated with elevated brain injury markers and reduced gray matter ...

Arnaud Denis, a 43-year-old French director and actor, passed away in Belgium on September 22, 2026. A few years ago, following surgery, he developed a very severe case of ME/CFS. He chose to under…

Scott Taylor never got to move on from COVID-19. The analysis was based on data from 20 major U.S. hospital systems, including more than 1.3 million adults with a COVID diagnosis and 19,000 with a lo...

AbstractObjective. Treatment of acute COVID-19 with anti-viral and immunomodulator medications demonstrates a reduced risk of long-term outcomes. To date,

Pilgrim at Tinker Creek, published when Dillard was 28, skyrocketed her to become one of the most prominent nonfiction writers of her generation

Long COVID (LC) is a multisystem condition that is linked to distinct pathologies including viral persistence, immunological dysfunction, endothelial damage, and mitochondrial dysfunction. To date, l...

Background and Aims Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), is a multisystem condition characterized by persistent symptoms that continue beyond the acute phase...

Abstract. Introduction: To objectify self-reported sleep disorders in individuals with post-COVID-syndrome (PCS), we aimed to investigate the prevalence and nature of sleep disturbances by polysomnogr...

Abstract. The coronavirus disease 2019 (COVID-19) pandemic has not only challenged global public health but also generated interest in its neurological bas